Additionally, some individuals prefer a slower dosing strategy to reduce discomfort
Denson TF
This medication works by binding to two receptors (GLP-1 and GIP) simultaneously to suppress appetite, support weight loss, and promote metabolic health
One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying
an unusual or allergic reaction to methylcobalamin, cobalt, other medicines, foods, dyes, or preservatives